About Us
Overview
Founding
Team
Investors
LYTAC Platform
Overview
Approach
Applications
Publications
Strategic Partners
News
Join Us
Lycia Therapeutics Announces $70 Million Series B Financing Led by Redmile Group with Participation from Founding Investor Versant Ventures